日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Coverage is the Key to Realizing the Promise of Semaglutide

覆盖范围是实现司美格鲁肽疗效的关键。

Gasoyan, Hamlet; Rothberg, Michael B

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023

2003年至2023年所有参与者肥胖药物及代谢和减肥手术使用趋势

Adekunle, Olajide A; Le, Phuc; Boyer, Christopher; Gasoyan, Hamlet; Gupta, Dev Yash; Tran, Ha T; Yue, Yihua; Rothberg, Michael B

Socio-demographic and clinical factors associated with the receipt of anti-obesity medication prescriptions and metabolic and bariatric surgery among eligible all of Us participants

符合条件的美国参与者中,与接受抗肥胖药物处方以及代谢和减肥手术相关的社会人口学和临床因素

Adekunle, Olajide A; Le, Phuc; Gupta, Dev Yash; Rothberg, Michael B; Tran, Ha T; Yue, Yihua; Gasoyan, Hamlet

Treatment Access among Younger Medicaid Beneficiaries with Multiple Myeloma

年轻医疗补助受益者多发性骨髓瘤的治疗机会

Fiala, Mark A; Ji, Mengmeng; Shih, Yi-Hsuan; Huber, John; Wang, Mei; Johnson, Kimberly J; Gasoyan, Hamlet; Wang, Rong; Colditz, Graham A; Wang, Shi-Yi; Chang, Su-Hsin

Changes in weight and glycemic control following obesity treatment with semaglutide or tirzepatide by discontinuation status

使用索玛鲁肽或替泽帕肽治疗肥胖症后,根据停药情况评估体重和血糖控制的变化

Gasoyan, Hamlet; Butsch, W Scott; Schulte, Rebecca; Casacchia, Nicholas J; Le, Phuc; Boyer, Christopher B; Griebeler, Marcio L; Burguera, Bartolome; Rothberg, Michael B

Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice

临床实践中停止使用司美格鲁肽或替拉帕肽治疗肥胖症的原因

Gasoyan, Hamlet; Butsch, W Scott; Casacchia, Nicholas J; Schulte, Rebecca; Criswell, Victoria; Fox, Jacqueline; Renner, Holly; Le, Phuc; Alpert, Jordan; Rothberg, Michael B

Disparities in Treatment for Alcohol Use Disorder Among All of Us Participants

我们所有参与者中酒精使用障碍治疗方面的差异

Le, Phuc; Rich, Jacob James; Bernstein, Eden Y; Glass, Joseph; Gasoyan, Hamlet; Back, Sudie E; Bui, Thanh C; Gina Ayers; Rothberg, Michael B

Disparities in time to treatment with oral antimyeloma medications

口服抗骨髓瘤药物治疗时间上的差异

Gasoyan, Hamlet; Anwer, Faiz; Kovach, Jeffrey D; Casacchia, Nicholas J; Wang, Ming; Valent, Jason; Halpern, Michael T; Rothberg, Michael B

One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice

临床实践中应用司美格鲁肽或利拉鲁肽进行一年减重的效果

Gasoyan, Hamlet; Pfoh, Elizabeth R; Schulte, Rebecca; Le, Phuc; Butsch, W Scott; Rothberg, Michael B

Association of patient characteristics and insurance type with anti-obesity medications prescribing and fills

患者特征和保险类型与抗肥胖药物处方和配药之间的关联

Gasoyan, Hamlet; Pfoh, Elizabeth R; Schulte, Rebecca; Sullivan, Erin; Le, Phuc; Rothberg, Michael B